 | | EU Clinical Trials Register | Help |
- Home & Search
- Joining a trial
- Contacts
- About
- About the EU clinical trials register
- What's new
- Data quality
- Clinical trial sponsors
- National medicine regulatory authorities
- Links
- News update
|
Clinical trials for 2017-002290-19
The European Union Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the Clinical Trials Information System (CTIS). The EU Clinical Trials Register currently displays 44232 clinical trials with a EudraCT protocol, of which 7336 are clinical trials conducted with subjects less than 18 years old. The register also displays information on 18700 older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006). Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ). Examples: Cancer AND drug name. Pneumonia AND sponsor name. How to search [pdf]
Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
| Advanced Search: | Search tools |
| Select Country: Austria Belgium Bulgaria Croatia Cyprus Czechia Denmark Estonia Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Liechtenstein Lithuania Luxembourg Malta Netherlands Norway Poland Portugal Romania Slovakia Slovenia Spain Sweden United Kingdom Outside EU/EEA | Select Age Range: Adolescent Adult Children Elderly In-Utero Infant and Toddler Newborn Preterm new born infants Under 18 |
| Select Trial Status: Completed Not Authorised Ongoing Prematurely Ended Prohibited by CA Restarted Suspended by CA Temporarily Halted Trial Now Transitioned | Select Trial Phase: Phase One Phase Two Phase Three Phase Four |
| Select Gender: Both Female Only Male Only |
| Select Date Range: to |
| Select Rare Disease: |
| IMP with orphan designation in the indication |
| Orphan Designation Number: |
| Results Status: Trials with results Trials without results |
| Clear advanced search filters |
Download Options Subscribe to this Search
- Trials with a EudraCT protocol (1)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
1 result(s) found for: 2017-002290-19. Displaying page 1 of 1.
| EudraCT Number: 2017-002290-19 | Sponsor Protocol Number: CC-5013-NHL-008 | Start Date*: 2017-12-07 |
| Sponsor Name:Celgene Corporation |
| Full Title: A Phase 3b randomized study of lenalidomide (CC-5013) plus rituximab maintenance therapy followed by lenalidomide single-agent maintenance versus rituximab maintenance in subjects with relapsed/ref... |
| Medical condition: relapsed/refractory follicular, marginal zone or mantle cell lymphoma |
| Disease: |
| Population Age: Adults, Elderly | Gender: Male, Female |
| Trial protocol: DE (Completed) |
| Trial results: (No results available) |
Subscribe to this Search To subscribe to the RSS feed for this search click here
. This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: |
| Number of Trials to download: |
| Trials shown on current page Selected Trials only |
| Download Content: |
| Summary Details Full Trial Details |
| Download Format: |
| Plain Text |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed • Outside EU/EEA: Date study was submitted in EudraCT 
Query did not match any studies. For support, Contact us. The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website. European Medicines Agency © 1995-Sat Nov 30 16:40:55 CET 2024 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands 
